982 results on '"Shimizu, Chikako"'
Search Results
2. Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale
3. Effect of a web-based fertility preservation training program for medical professionals in Japan
4. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
5. Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma
6. Immunotherapy For US Patients With Metastatic Cancer at the End of Life
7. Older patients’ experience of living with cognitive impairment related to hormone therapy for breast cancer: A qualitative study
8. Malting and Brewing Performance of β-Amylase-Deficient Barley.
9. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
10. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
11. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
12. Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
13. Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy
14. Immunohistochemical profiling of HIF-2[alpha] and SSTR2 with the tumor microenvironment in metastatic pheochromocytoma and paraganglioma
15. Correction to: Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
16. Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry
17. Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
18. Abstract 15699: High-Dose Anthracycline Administration and Development of Cardiotoxicity in Women With Breast Cancer: An Analysis of Real-World Data From a Nationwide Claims Database in Japan
19. Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3
20. Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
21. Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers
22. Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan
23. Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale
24. Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?
25. Shorter Duration of Trastuzumab Combined With Chemotherapy for Early Breast Cancer.
26. Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
27. Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method
28. Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
29. Preferences Regarding End-of-Life Care Among Adolescents and Young Adults With Cancer: Results From a Comprehensive Multicenter Survey in Japan
30. Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists
31. O5-1 Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale
32. Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast Health
33. MO29-3 Transition of childhood cancer survivors to adult care – what we have learned from the experience of Cancer Survivorship Clinic over the past 3 years
34. Oral Selective Estrogen Receptor Degrader for Advanced Breast Cancer
35. Pharmacotherapy decision-making among patients with breast cancer in Japan: results of an online survey
36. Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population
37. Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40–44 years
38. What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists
39. Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients
40. Current situation of cancer among adolescents and young adults in Japan
41. Correction to: Current situation of cancer among adolescents and young adults in Japan
42. Distress and impacts on daily life from appearance changes due to cancer treatment: A survey of 1,034 patients in Japan
43. Current Status and Issues of the Japan Oncofertility Registry
44. Severe cytopenia during adjuvant chemotherapy for early breast cancer in a patient with idiopathic CD4+ lymphocytopenia
45. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index
46. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
47. Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
48. The effects of an educational program for non-physician health care providers regarding fertility preservation
49. Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study
50. Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.